Knee Hurt

Blog

  • Centinel Spine® Worldwide prodisc® Total Disc Replacement Momentum Continues in Q3 2023 with 61% YoY Growth

    Centinel Spine® Worldwide prodisc® Total Disc Replacement Momentum Continues in Q3 2023 with 61% YoY Growth

     

    • Third Quarter 2023 US prodisk® Total Disc Replacement (TDR) sales reached nearly $14 million in sales – a new record – surpassing the second quarter of 2023, the company’s previous best quarter.
    • Third quarter 2023 worldwide proDisc TDR remained strong by product segment, with global lumbar TDR growing 43% – a new sales record – and global cervical TDR growing 75%.
    • Year-to-date worldwide proDisc TDR revenues of $49 million in the third quarter are up 55% year-over-year.
    • Strong global revenue growth and operating performance resulted in Centinel Spine’s second consecutive EBITDA positive quarter.

    WEST CHESTER, Pa., Nov. 2, 2023 /PRNewswire/ — Centinel Spine®LLC, (“the Company”), the leading global medical device company addressing cervical and lumbar spine diseases with the world’s most clinically proven total disc replacement (TDR) technology platform (prodisk®), today announced record third quarter 2023 prodisk TDR financial results. Strong operating performance combined with global revenue growth of 61% year-on-year in Q3 2023 saw the company achieve its second consecutive EBITDA-positive quarter. Centinel Spine’s strong quarterly results were driven by record numbers of professionalsdisk surgeon users, as well as accelerated procedure volume and user acceptance of the company’s new professionaldrive C I’m alive and prodisk C SK cervical TDR system.

    According to one of the early adopters of the new prodisk cervical system neurosurgeon John S. Shiau, MD, of Maplewood, NJ and Manhattan, NY: “I believe in the benefits of cervical disc replacement over fusion in my patients. The functional recovery and long-term results are fantastic. I am very pleased with the various disc replacements available from Centinel Spine. I can choose the implant that best achieves my surgical goals of functional stabilization. In addition, I can choose the implant that fits the anatomy, instead of matching the anatomy to the implant. This maximizes the chance of successful results in my patients. For these reasons, depending on the clinical setting, I continue to use both the original prodisk C implant and the professionaldrive C I’m alive implant. For example, if the superior end plate is flat, then the prodisk C fits the anatomy better; if the end plate is concave, I choose the domed prodrive C I’m alive. The proffesionaldrive C I’m alive implant is an improvement in terms of ease of insertion.”

    Centinel Spine CEO Steve Murray said: “We are pleased with the progress Centinel Spine is making in the overall disc replacement market this year. The company is exclusively and completely focused on becoming the unrivaled leader in TDR and expanding the market as we grow. In both cervical and lumbar disc replacement, surgeons see the benefit of our Match-the-Disc family of anatomic discs. The clinical benefits of total disc replacement are clearly and impeccably reported in the many studies examining its safety and effectiveness – and patients are increasingly seeking treatment options that preserve motion and reduce the likelihood of future surgery. We will continue to do our utmost to improve patient care in everything we do.”

    Highlights third quarter 2023

    Q3 2023 worldwide prodisk Franchise sales exceeded $17 million, up 61% from last year, with prodisk cervical growth 75% and prodisk lumbar increase by 43% compared to 2022.

    American profdisk turnover grew by 71% in the third quarter compared to last year. Quarterly revenue reached a record $14 million, thanks to the continued success of the new professionaldrive C I’m alive and prodisk C SK cervical TDR system and almost 40% year-over-year prodisk lumbar growth. American profdisk Cervical cancer revenue grew by more than 100% in the third quarter of 2023 compared to last year.

    The American Profdisk Surgeon user base grew more than 50% year-over-year, including 70% growth in prodisk cervical users. New professionaldisk the number of users has more than tripled from the third quarter of 2022. Additionally, the total number of US healthcare facilities that prodisk TDR products exceeded 465, up 45% year-over-year, and the number of distributors selling pro productsdisk almost 30% growth compared to the third quarter of 2022.

    International Q3 2023 prodisk TDR’s revenue grew 30% from Q3 2022, driven by 85% growth in prodisk lumbar sales.

    Highlights on new cervical prodisc TDR system One year after US launch

    Acceptance by the American market of the new professionaldrive C I’m alive and prodisk S.K system remains strong, with nearly 380 surgeons now using the system – a sequential user growth of nearly 30% in the second quarter of 2023. The company reached the milestone of 2,500 procedures with the new prodrive C I’m alive and prodisk c S.K system in September, just five months after hitting 1,000e The case was announced in April 2023. In the third quarter of 2023, almost 900 procedures were completed with the new system, a volume growth of 15% over the second quarter of 2023.

    The average monthly user base of US surgeons for the new professionaldrive C I’m alive and prodisk c S.K the system continued to grow in the third quarter of 2023, with an increase of almost 10% compared to the previous quarter. The proffesionaldrive C I’m alive and prodisk C S.K The surgeon user base also remains committed to the new system, with the majority being competitive conversions and returning users.

    2023 performance to date

    Year-to-date September 2023 worldwide prodisk TDR revenue of $49 million represents a 55% year-over-year increase. Record sales across all geographic segments were also strong through the first nine months of 2023, with year-over-year gains in the US.disk turnover is growing by 61% and international turnover is growing by 36%. The growth in the number of new surgeons has been driven by the company’s medical education programs, which have trained more than 750 surgeons to date.

    Year-to-date Q3 US prodisk TDR’s revenue approached $38 million, driven by a rapidly growing user base of surgeons and repeat use within its existing customer base. Until the third quarter, the American prodisk The user base of TDR surgeons has increased by more than 50% year over year.

    The year-over-year growth of the US prodisk The cervical surgeon base was particularly strong, growing over 65% through the end of the third quarter of 2023. Finally, more than 85% of the pro grewdisk The TDR cervical surgeon user base has seen repeated use since the beginning of the year compared to the same period in 2022.

    Year-to-date Q3 International prodisk TDR revenues are up 36% in 2022, driven by 55% prodisk lumbar growth and prodisk sales growth of cervical products by 30% by 2022.

    Outlook for the full year 2023

    Looking ahead to full year 2023, the company has increased its projection and anticipates its global benefitsdisk TDR business will exceed 50% year-on-year, significantly exceeding expected market growth of 11% (source: Artificial Drives Market Insights, Competitive Landscape and Market Forecast-2027, DelveInsight Business Research LLP, 2022). The full year growth will come from the prosdisk global lumbar activities and continued expansion of the recently launched prodrive C I’m alive and prodisk c S.K cervical system.

    About Centinel Spine, LLC

    Centinel spine®LLC is the leading global medical device company addressing cervical and lumbar spine diseases with the world’s most clinically proven total disc replacement (TDR) technology platform (prodisk®). The company’s prodisk technology is the most studied and clinically proven TDR system in the world, validated by more than 540 published articles and more than 250,000 implantations worldwide.

    Centinel Spine continues to advance its pioneering culture and corporate mission to become a catalyst for change in the spine industry and change the way spine surgery is experienced. The proffesionaldisk platform remains the only technology with multiple motion preservation solutions for both cervical and lumbar anterior column reconstruction.

    For more information, please visit the company’s website at www.CentinelSpine.com or contact:

    Varun Gandhi
    Finance Director
    900 Airport Road, Suite 3B
    West Chester, PA 19380
    Phone: 484-887-8871
    Email: v.gandhi@centinelspine.com

    SOURCE Centinel Spine, LLC

    rt

    Source link

  • Sports such as football and basketball are better for the bone health of young athletes than running alone

    Sports such as football and basketball are better for the bone health of young athletes than running alone

     

    Young athletes who participate in multi-directional sports, rather than specializing in a uni-directional sport like running, can build stronger bones that may be at less risk of bone injuries as adults, according to a new study from researchers at Indiana University.

    The study, published in the American College of Sports Medicine’s Medicine and Science in Sports and Exercise, examined Division I and II female cross-country runners, who often suffer from bone stress injuries such as stress fractures. The researchers found that athletes who ran at a younger age and participated in sports that require movement in many directions – such as basketball or football – had better bone structure and strength than those who only walked, swam or cycled.

    As a result, the study’s findings support recommendations that athletes delay specialization in running and practice multi-directional sports when they are younger, to build a more robust skeleton – and possibly prevent bone stress injuries.

    “Our data shows that playing multi-directional sports at a younger age rather than specializing in one sport, such as running, reduces a person’s risk of bone injuries by developing a larger, stronger skeleton,” said Stuart Warden, associate dean for research and Chancellor’s Professor at the IU School. of Health and Human Sciences at IUPUI. “There is a common misconception that children need to specialize in a single sport to succeed at the next level. However, recent data indicate that athletes who specialize at a young age are at greater risk of an overuse injury and are less likely to progress to another sport. higher levels of competition.”

    Historically, Warden said, researchers have examined bone mass — how much bone a person has — to determine how healthy their skeleton will be throughout life. But in previous studies, Warden and his colleagues found that as a person ages, both mass and size are equally important.

    In the current study, the researchers used high-resolution imaging to assess the tibia near the ankle and the bones in the feet, where bone strain injuries are common in runners. They found that the athletes who participated in both running and multi-directional sports at a younger age had 10 to 20 percent more bone strength than athletes who only ran.

    “Our research shows that the runners who participated in multi-directional sports at a young age had stronger bones than collegiate athletes, putting them at lower risk for bone stress injuries, including stress fractures,” Warden said. “We want to ensure that people have better, stronger bones as they grow, become adolescents and go through life. If they specialize in one sport at too young an age, they are more likely to get injured and not make it to collegiate and professional level.”

    Warden said anyone supervising a junior athlete or team — whether parents, coaches or trainers — should think twice about forcing them to specialize in one area too early. To allow for proper growth and development, he recommends that young athletes not specialize until their freshman year of high school. For athletes who already play multi-directional sports, he said it’s important that they take time off during the year for rest and recovery, which can improve both bone strength and performance.

    Other authors of the study included Austin Sventeckis, Ph.D. student, and Robyn Fuchs, associate professor, from the IU School of Health and Human Sciences at IUPUI, and Rachel Surowiec from the School of Engineering and Technology at IUPUI.

    Source link

  • Sports such as football and basketball are better for the bone health of young athletes than running alone

    Sports such as football and basketball are better for the bone health of young athletes than running alone

     

    Young athletes who participate in multi-directional sports, rather than specializing in a uni-directional sport like running, can build stronger bones that may be at less risk of bone injuries as adults, according to a new study from researchers at Indiana University.

    The study, published in the American College of Sports Medicine’s Medicine and Science in Sports and Exercise, examined Division I and II female cross-country runners, who often suffer from bone stress injuries such as stress fractures. The researchers found that athletes who ran at a younger age and participated in sports that require movement in many directions – such as basketball or football – had better bone structure and strength than those who only walked, swam or cycled.

    As a result, the study’s findings support recommendations that athletes delay specialization in running and practice multi-directional sports when they are younger, to build a more robust skeleton – and possibly prevent bone stress injuries.

    “Our data shows that playing multi-directional sports at a younger age rather than specializing in one sport, such as running, reduces a person’s risk of bone injuries by developing a larger, stronger skeleton,” said Stuart Warden, associate dean for research and Chancellor’s Professor at the IU School. of Health and Human Sciences at IUPUI. “There is a common misconception that children need to specialize in a single sport to succeed at the next level. However, recent data indicate that athletes who specialize at a young age are at greater risk of an overuse injury and are less likely to progress to another sport. higher levels of competition.”

    Historically, Warden said, researchers have examined bone mass — how much bone a person has — to determine how healthy their skeleton will be throughout life. But in previous studies, Warden and his colleagues found that as a person ages, both mass and size are equally important.

    In the current study, the researchers used high-resolution imaging to assess the tibia near the ankle and the bones in the feet, where bone strain injuries are common in runners. They found that the athletes who participated in both running and multi-directional sports at a younger age had 10 to 20 percent more bone strength than athletes who only ran.

    “Our research shows that the runners who participated in multi-directional sports at a younger age had stronger bones than collegiate athletes, putting them at lower risk for bone stress injuries, including stress fractures,” Warden said. “We want to ensure that people have better, stronger bones as they grow, become adolescents and go through life. If they specialize in one sport at too young an age, they are more likely to get injured and not make it to collegiate and professional level.”

    Warden said anyone supervising a junior athlete or team — whether parents, coaches or trainers — should think twice about forcing them to specialize in one area too early. To allow for proper growth and development, he recommends that young athletes not specialize until their freshman year of high school. For athletes who already play multi-directional sports, he said it’s important that they take time off during the year for rest and recovery, which can improve both bone strength and performance.

    Other authors of the study included Austin Sventeckis, Ph.D. student, and Robyn Fuchs, associate professor, from the IU School of Health and Human Sciences at IUPUI, and Rachel Surowiec from the School of Engineering and Technology at IUPUI.

    Source link

  • Record Number of Midwestern Orthopedics at RUSH Physicians Named to Chicago Magazine’s “TOP DOCS” List

    Record Number of Midwestern Orthopedics at RUSH Physicians Named to Chicago Magazine’s “TOP DOCS” List

     

    CHICAGO , Nov. 2, 2023 /PRNewswire/ — A record 15 Midwest Orthopedics physicians at RUSH (MOR) were named to Chicago Magazine’s “Top Docs” list. The “Top Docs” list, compiled by Castle Connelly, a physician-led healthcare research and information company, features Chicago-area physicians selected by their peers.

    The MOR physicians on this list are Drs. Charles Bush Joseph, Brian Forsythe, Grant Garrigues, Eduard Goudberg, Joshua Jacobs, Dennis Name, Shane Nho, Frank Phillips, Nikhil VermaAnd Adam Cut (orthopedic surgery category); Drs. Mark Cohen, John Fernandez, And Robert Wysocki (hand surgery category); Dr. Joshua Blomgren (sports medicine category); And Dr. Leda Ghannad (physical medicine and rehabilitation category).

    This is the highest number of MOR physicians named to this honor since the popular list began published in Chicago Magazine.

    About Midwest Orthopedics at RUSH

    MOR is an international leader in musculoskeletal health and is ranked among the top ten in the country American news and world report. MOR consists of renowned orthopedic and spine surgeons who pioneer the latest developments in surgical techniques and non-surgical care. MOR physicians are the designated team care providers for several organizations, including the Chicago Bulls, Chicago White Sox, Chicago Red Stars and Joffrey Ballet. MOR has seven full-service locations in Chicago, Joliet, Naperville, Oak Brook, Oak Park, Westchester and Munster, IN. The group also operates nine standalone physical therapy clinics in Bensenville, Chicago’s South Loop, Geneva, Lincoln Park, Lockport, Orland Park, River Grove, Park Ridge and Munster, IN. Visit www.rushortho.com for more information.

    SOURCE Midwest Orthopedics at RUSH

    rt

    Source link

  • Freedom in shoes – Shoe types have little to no effect on the number of injuries

    Freedom in shoes – Shoe types have little to no effect on the number of injuries

     

    Running shoes to prevent running injuries to the lower extremities in adults

    Relph N, Greaves H, Armstrong R, Prior TD, Spencer S, Griffiths IB, Dey P, Langley B. Cochrane Database of Systematic Reviews. August 2022. doi: 10.1002/14651858.CD013368.pub2.
    https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013368.pub2/full

    Take home message

    Prescribing running shoes based on foot type and general footwear type (e.g., motion control, neutral, stability, minimalist) does not reduce the number of lower extremity running injuries.

    Background

    Most running injuries occur in the lower extremities and 20-80% of runners sustain an injury. To reduce the risk of injury, runners are often prescribed specific shoes based on their foot type, based on the idea that the shoe can optimize foot position while running. However, it remains unclear whether running shoes prevent injuries.

    Study aim

    The authors conducted a systematic review to assess whether running shoes prevent lower extremity injuries in different adult runners.

    Methods

    Authors identified randomized (or quasi-randomized) controlled trials among runners (entry to elite level) or military personnel that compared running shoes or studied prescription running shoes based on foot type versus non-prescription shoes. The main outcomes were the number of runners who sustained a lower extremity running injury and the number of lower extremity running injuries. Secondary outcomes included satisfaction with the footwear, side effects (such as blisters) and anyone requiring hospitalization or surgery. The authors found twelve studies that met the inclusion criteria, leading to a total analysis of 11,240 runners.

    Results

    The types of shoes used were 1) neutral/cushioned (intended to reduce footfall stress), 2) motion control (intended to reduce foot movement during stance), 3) stability (provides motion control and cushioning), and 4) minimalist (intended to simulate barefoot running with small aids). The authors found no clear differences in injuries between 1) neutral/cushioned and minimalist shoes (5 studies, 766 participants), 2) motion control and neutral/cushioned shoes (2 studies, 421 participants), and 3) soft and hard shoes (2). studies, 1,095 participants). However, the authors found evidence that runners with a body weight of more than 71.4 kg had a greater risk of injury when wearing minimalist shoes instead of neutral/cushioned shoes. Runners wearing prescription (based on foot structure) or non-prescription shoes had similar injury rates, with moderate certainty (3 studies, 7,203 participants). Runners had similar shoe satisfaction between neutral and minimalist shoes.

    Viewpoints

    Overall, running shoes may not change runners’ risk for lower extremity running injuries. However, pronators reported pain when wearing motion control shoes compared to neutral or stability shoes, and runners with neutral feet reported more pain in motion control shoes than in neutral shoes. These findings were based on a low level of evidence and may be due to the fact that each study used different definitions of shoe types. However, we must interpret all results with caution due to the small sample size. Furthermore, the participants were recreational runners and military personnel. Running shoe researchers should have standard definitions for types of shoes, and large-scale studies are needed to understand whether prescribing running shoes based on foot structure and type can reduce running injuries to the lower extremities.

    Clinical implicationS

    Despite common advertising and beliefs, doctors should explain to runners that specific running shoes cannot reduce injuries. It may be more helpful to advocate that runners purchase comfortable running shoes.

    Questions for discussion

    What kind of advice have you given athletes looking for running shoes? Have you familiarized yourself with shoe types in order to provide advice?

    related posts

    1. Dampen the blow: Softer midsole shoes reduce the risk of injury for recreational runners
    2. What shoes protect those who protect us?
    3. Pronated and Neutral wins the race… or at least keeps the runners in it

    Written by Jennifer Xu
    Reviewed by Jeffrey Driban

    Source link

  • Spineway- US 2023 NASS Conference: VEOS System

    Spineway- US 2023 NASS Conference: VEOS System

     

    VEOS system well received at the NASS 2023 conference
    in the United States

    Sales growth in France

    Ecully, November 2, 2023 – Spineway Group, specialist in innovative implants for the treatment of serious spinal pathologies, is pleased to announce that its VEOS posterior spinal fixation system received an excellent response from the spinal implant industry at the North American Spine Society (NASS) Congress in Los Angeles last year. October1.

    During the event, the Group received numerous expressions of interest for its VEOS restraint system, which has received 510(k) clearance from the Food and Drug Administration (FDA), and established contacts with potential US partners for its distribution in the USA This innovative platform offers spine surgeons a unique modularity, as the rational organization of the implant and instrument kits allows them to perform many different types of procedures with a single system, both in open and minimally invasive surgery (MIS).

    As a reminder, the VEOS range is one of a number of Distimp2 products that now represent a significant part of the Group’s turnover in France. In the first nine months of 2023, Distimp’s sales in France increased by 45% compared to 2022, mainly driven by the success of the VEOS range at a large number of French healthcare institutions, including several university hospitals.

    This trend should continue if sales of the VEOS range start in Spain before the end of 2023.

    Thanks to these first positive developments, Spineway will continue its development plans, which is a confirmation its goal to become an innovative player in France and internationally, leader in less invasive spine treatments.

    Next events:
    November 10, 2023: Extraordinary General Meeting

    SPINEWAY ELIGIBLE FOR PEA-SME (Small and Medium Business Equity Savings Plans)
    Find out all about Spineway at www.spineway.com

    This press release has been drawn up in both English and French. In case of contradictions, the French version shall prevail.

    Spineway designs, produces and sells innovative implants and surgical instruments for the treatment of serious spinal conditions.
    Spineway has an international network of more than 50 independent distributors and 90% of its turnover comes from exports.
    Spineway, which is eligible for investment through FCPIs (French unit trusts specialized in innovation), has received the OSEO Excellence Award since 2011 and the Deloitte Fast 50 Award (2011). Rhône Alpes INPI Patent Innovation Award (2013) – INPI Talent Award (2015).
    ISIN: FR001400BVK2 – ALSPW

    Contacts:

    SPINEWAY

    Shareholder services line

    Available from Tuesday to Thursday

    +33 (0)806 706 060

    		 Eligible PEA/PME

    ALSPW

    Euronext growth

    		 HEAVEN

    Finance & Communications

    Relations with investors

    Solène Kennis

    Spineway@aelium.fr

    1 Press release dated October 19, 2023, NASS Congress October 18-20, 2023, Los Angeles, USA.
    2 Company acquired in 2021

    SPINEWAY

    Source link

  • New research shows a better way to easily assess knee muscle function

    New research shows a better way to easily assess knee muscle function

     

    Muscle strength and its improvement are important for everyone for their daily activities. Conventionally, muscle function can be assessed through physical performance tests and/or muscle strength measurements. However, these methods are not applicable to people who cannot undergo forceful muscle contractions, such as infants, the elderly, and patients with injuries or cognitive impairment (such as dementia).

    A simple and popular alternative is the use of bioelectrical impedance analysis (BIA), which can quickly and non-invasively measure tissue resistance (which depends on the amount of water and electrolytes present in the tissue) and reactance (which depends on the integrity of the cell) can be measured. membrane). Phase angle (PhA), a measurement derived via BIA, is calculated using the resistance and reactance of the tissue. It is directly proportional to muscle cell mass and function. Many studies have linked PhA across the body to maximal muscle strength, but none associate PhA with knee extension strength or explosive muscle strength (the force required to make fast, powerful movements such as sprinting or standing up from a chair) in adults. Taking into account the importance of knee muscle strength – especially in the elderly, who need it for their independence, and athletes, who need strong knees for better performance – such a study was necessary.

    In this spirit, a group of scientists, including Professor Ryota Akagi, from the College of Systems Engineering and Science, Shibaura Institute of Technology (SIT); Assistant Professor Kosuke Hirata from the Faculty of Sports Sciences, Waseda University; and researchers Yosuke Yamada and Tsukasa Yoshida from the Healthy Longevity Research Section, National Institute of Health and Nutrition, National Institutes of Biomedical Innovation, Health and Nutrition examined the association of PhA with the neuromuscular properties of knee extensor muscles in both young and older people. adults. Their findings were published in Part 13 of Frontiers in physiology on August 11, 2022. Dr. Akagi and Dr. Hirata, the corresponding authors of the paper, tell us: “We wanted to assess the association of PhA in the thigh with maximal muscle strength, explosive muscle strength, contractile properties and neuromuscular activity. and find out which of the two – whole body PhA or the thigh – was a better predictor of knee extensor strength.

    The team measured the PhA of the whole body and thighs of 55 participants (23 young men and 32 older men) at 50 kHz. Participants were asked to perform a 4-second maximal voluntary isometric contraction (MVIC) to measure peak torque (PT).MVIC) and a 1 second MVIC to measure the rate of torque development (RTD) over a time difference of 0-200 milliseconds. The average mean value of these three measurements (i.e. PTMVIC and RTD) was used for further analysis. Contractile properties were also analyzed because they are significant markers of the mechanisms underlying force generation in the muscles. Finally, muscle activity was assessed by electromyography (EMG-RMS).

    The study findings showed that both whole-body and thigh PhAs are associated with knee extensor muscle strength (with thigh PhA being the preferred predictor of knee extensor strength). However, this association was thought to be due to the contractile properties of the muscles and not to neural aspects. Thus, both measures could not predict neuromuscular activity or explosive muscle strength (which largely depends on neuromuscular control) of knee extensors.

    This study is promising for current and future implications. Speaking of the present, being able to assess knee muscle strength is very important, especially for the elderly (where strong knee muscles mean greater independence in movement) and athletes (who need to maintain knee muscle strength to perform better ). . The above findings demonstrate a new way to assess muscle strength not only for healthy adults, but also for people suffering from orthopedic or cognitive disorders. And speaking about the future, Dr. Akagi shows us the implications of their work: “People can assess their muscle condition in just a few seconds using BIA. In the future, we may be able to build a system that uses a person’s BIA to provide them with advice to promote their health.”

    Source link

  • Who participates in youth sports?

    Who participates in youth sports?

     

    Organized sports participation among children aged 6–17 years: United States, 2020

    Black LI, Terlizzi EP, Vahratian A. National Center for Health Statistics (US). Publication date: 08/11/2022. Series: data overview; No. 441

    https://stacks.cdc.gov/view/cdc/119026

    Take home message

    Sports participation was lower among racial and ethnic minority children, children whose parents had lower education or income, children living in counties with greater social vulnerability, and children living in the southern United States.

    Background

    Youth participation in sports is associated with better physical fitness and mental health. Understanding the differences in sports participation can help inform strategies to promote active lifestyles among children and adolescents, which positively impacts their physical and mental health.

    Study aim

    Black and colleagues completed an analysis of data from the 2020 National Health Interview Survey to describe disparities in sports participation in the United States.

    Methods

    The authors analyzed data from the 2020 National Health Interview Survey. This survey is a nationally representative household survey conducted throughout the year. Parents reported whether their child participated in a sports team or club or took sports lessons at school or in the community in the previous 12 months. The authors then collected data on household income as a percentage of the federal poverty level, race and Hispanic origin, geographic region (Northeast US, Midwest US, Southern US, or Western US), social vulnerability of a county, and urbanicity ( urban region). -national classification) of a province.

    Results

    About half (54%) of children aged 6 to 17 have played sports in the past twelve months (boys: 56%; girls: 52%). The authors reported: “Participation levels were lower among children from racial and ethnic minority groups, children whose parents had lower levels of education and family income, children living in counties with greater social vulnerability, and children living in the South.”

    Black Graph

    Viewpoints

    The results of this letter provide a surprising snapshot of sports participation in the United States. While it is established that early sports participation can have a positive impact on an individual, significant differences still exist. These findings indicate that sports participation is strongly associated with socioeconomic status. Ultimately, a higher socio-economic status can ensure children’s access to sports. This is particularly reflected in the fact that lower parental education, lower parental income and lower geographical area of ​​social vulnerability are all associated with lower participation. These findings complement data from the Athletic Training Locations and Services Database, which shows that these communities also have less access to athletic training services.

    This data provided a unique snapshot of 2020, when many sports shut down in the spring due to the COVID-19 pandemic. The survey asked about sports participation over the past year, so it is unclear whether the pandemic could influence these results. Furthermore, not every community is recovering from the pandemic in the same way. The authors acknowledge that it will be essential to replicate these analyzes with data from the 2022 survey to better understand patterns of sports participation after many of the restrictions associated with the pandemic are relaxed/removed.

    Clinical implications

    Sports medicine professionals should advocate for increased access to sports through local recreation organizations, schools, and other organizations. In regions with high social vulnerability, we should encourage policymakers that investments in youth sports and physical activity can help improve community health.

    Questions for discussion

    What can we do as doctors to positively influence participation in team sports?

    Written by: Kyle Harris
    Review by: Jeffrey Driban

    related posts

    Asian Pacific Society of Cardiology Consensus Recommendations for Pre-Participation Screening in Young Competitive Athletes
    A lasting impression: youth sports participation and healthy habits as adults
    Previous participation in collision sports is associated with reduced quality of life
    Lower socioeconomic status is associated with less access to athletic training services

    9 EBP CEU courses

    Source link

  • Stryker reports third-quarter 2023 operating results

    Stryker reports third-quarter 2023 operating results

     

    Kalamazoo, Mich., Nov. 2, 2023 (GLOBE NEWSWIRE) — Stryker (NYSE:SYK) reported operating results for the third quarter of 2023:

    Third quarter Results

    • Reported net sales increased 9.6% Unpleasant $4.9 billion
    • Organic net sales increased 9.2%
    • Reported operating profit margin of 19.0%
    • Adjusted operating income margin(1) increased 110 bps to 23.4%
    • Reported earnings per share fell 15.9% to $1.80
    • Custom EPS(1) increased 16.0% Unpleasant $2.46
    Overview of net sales growth in the third quarter
    Reported Exchange foreign currencies Constant currency Acquisitions / divestments Biological
    MedSurg and neurotechnology 10.5 % 0.2 % 10.3 % 0.2 % 10.1 %
    Orthopedics and spine 8.4 0.4 8.0 — 8.0
    Total 9.6 % 0.3 % 9.3 % 0.1 % 9.2 %

    “We delivered another quarter of strong organic revenue growth and continued margin expansion,” said Kevin A. Lobo, chairman and CEO. “The positive momentum in our business remains intact, including a strong procedural environment and our super cycle of innovation.”

    Sales analysis

    Consolidated net sales of $4.9 billion increased 9.6% in the quarter and 9.3% at constant exchange rates. Organic net sales increased by 9.2% in the quarter, of which 8.9% due to higher unit volume and 0.3% due to higher prices.

    MedSurg and Neurotechnology net sales of $2.9 billion increased 10.5% in the quarter and 10.3% at constant exchange rates. Organic net sales increased by 10.1% in the quarter, of which 8.7% due to higher unit volume and 1.4% due to higher prices.

    Orthopedics and Spine net sales of $2.1 billion increased 8.4% in the quarter and 8.0% at constant exchange rates. Organic net sales increased 8.0% in the quarter, of which 9.1% was due to higher unit volume, partially offset by 1.1% due to lower prices.

    Revenue Analysis

    Reported net income of $692 million fell 15.2% in the quarter. Reported net income per diluted share of $1.80 fell 15.9% in the quarter. Reported gross profit margin and reported operating profit margin were 64.3% and 19.0% in the quarter. The reported net profit includes certain items, such as costs for acquisition and integration-related activities, the amortization of purchased intangible assets, structural optimization and other special costs (including depreciation and impairment of assets), costs to comply with certain regulatory requirements medical devices, recall-related matters, regulatory and legal matters and tax matters. Excluding the above items, adjusted gross profit margin(1) was 64.7% in the quarter, and an adjusted operating income margin(1) amounted to 23.4% in the quarter. Adjusted net profit(1) of $944 million rose 16.5% in the quarter. Adjusted net income per diluted share(1) of $2.46 rose 16.0% in the quarter.

    Outlook for 2023

    Given our year-to-date performance, robust capital equipment backlog and continued positive procedural trends, we now expect organic net sales growth for full year 2023(2) between 10.0% and 10.5%, including slightly positive prices for the year. If exchange rates remain near their current levels, we expect net sales to be adversely affected by approximately 0.6% and adjusted net earnings per diluted share(2) will be adversely affected by $0.10 to $0.15 for the full year, both of which are included in our guidance. Based on our performance in the first nine months of the year, together with our strong sales momentum, we now expect adjusted net income per diluted share(2) are between $10.35 and $10.45.

    (1) A reconciliation of the non-GAAP financial measures: adjusted gross profit margin, adjusted operating income and adjusted operating income margin, adjusted net income and adjusted net income per diluted share, with the most directly comparable GAAP measures: gross profit margin, operating income and operating income margin, net income and net income per diluted share, and other important information are attached to this press release.

    (2) We are unable to provide a quantitative reconciliation between our expected net sales growth and expected organic net sales growth because we are unable to estimate with reasonable certainty and without unreasonable effort the impact and timing of acquisitions and divestitures and the impact of foreign currency exchange rates. We are unable to present a quantitative reconciliation between our expected net income per diluted share and expected adjusted net income per diluted share because we cannot estimate with reasonable certainty and without unreasonable effort the impact and timing of structural optimization and other special costs, acquisitions and predict takeovers. -related costs and adjustments to the fair value of inventories and the outcome of certain regulatory, legal and tax matters. The financial impact of these items is uncertain and depends on several factors, including timing, and could be material to our consolidated statements of operations.

    Conference call enabled Thursday November 2, 2023

    As previously announced, we are organizing a conference call Thursday November 2, 2023 at 4:30 p.m., Eastern Time, to discuss our operating results for the quarter ended September 30, 2023 and provide an operational update.

    Register for this conference call at: https://www.veracast.com/webcasts/stryker/events/SYK3Q23.cfm. Once registered, an email confirmation will be sent, including dial-in information and unique conference call access codes required for call entry. Registration is open during the live call. To ensure that you are connected before the start of the call, we recommend that you register at least 15 minutes before the start of the call.

    A simultaneous webcast of the call will be accessible via the Investor Relations page of our website at www.stryker.com. For those who do not intend to ask a management question, we recommend listening via the webcast. Please allow 15 minutes to register, download and install the necessary software.

    A replay will be available on our website following the conference call for up to one year from the time of the earnings call.

    Caution Regarding Forward-Looking Statements

    This press release contains information that contains or is based on forward-looking statements within the meaning of the federal securities laws, which are subject to various risks and uncertainties that could cause our actual results to differ materially from those expressed or implied by such statements. Such factors include, but are not limited to: weakening of economic conditions, or anticipation thereof, which could adversely affect the level of demand for our products; pricing pressures generally, including cost control measures that could adversely affect the price of or demand for our products; changes in the foreign exchange markets; legislative and regulatory actions; unexpected issues arising in connection with clinical trials and otherwise affecting the approval of new products by the U.S. Food and Drug Administration; inflationary pressure; higher interest rates; supply chain disruptions; changes in reimbursement levels from third-party payers; a significant increase in product liability claims; the final total costs related to recall-related matters; the impact of investigative and legal proceedings and compliance risks; settlement of tax audits; changes in tax laws and regulations; the impact of federal legislation to reform the United States health care system; costs to comply with medical device regulations; changes in the financial markets; changes in our credit ratings; changes in the competitive environment; our ability to integrate and realize the expected benefits of acquisitions in full or within the expected time frames; our ability to achieve expected cost savings; potential negative impacts resulting from environmental, social and governance (ESG) and sustainability issues; the impact on our operations and financial results of a public health emergency and related policies and actions of governments or other third parties; and breaches or failures of our or our suppliers’ information technology systems or products, including through cyber-attacks, data breaches, unauthorized access or theft. Additional information about these and other factors is included in our filings with the U.S. Securities and Exchange Commission, including our Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. We disclaim any intention or obligation to publicly update or revise any forward-looking statements to reflect any change in our expectations or in events, conditions or circumstances on which those expectations may be based or that could affect the likelihood that actual results will occur differ from the results. included in the forward-looking statements.

    Stryker is one of the world’s leading medical technology companies, and together with our customers, we are passionate about making healthcare better. We provide innovative products and services in medical, surgical, neurotechnology, orthopedics and spine that help improve patient and healthcare outcomes. In addition to our customers around the world, Stryker impacts more than 130 million patients annually. More information is available at www.stryker.com.

    For investor questions, please contact:

    Jason Beach, Vice President, Investor Relations at 269-385-2600 or jason.beach@stryker.com

    For media inquiries please contact:

    Yin Becker, Vice President, Chief Corporate Affairs Officer at 269-385-2600 or yin.becker@stryker.com

    SEE FINANCES HERE

    Source link

  • Tennis Elbow: What It Is and How to Treat It | Foothills Physical Therapy and Sports Medicine

    Tennis Elbow: What It Is and How to Treat It | Foothills Physical Therapy and Sports Medicine

     

    by Adam Halseth PT, DPT, SCS | Northeast Scottsdale

    Tennis elbow or golfer’s elbow is an uncommon condition. It just has an impact about 1 to 3 percent of adults every year. But your chances of developing it increase as you get older. Although the name suggests it is a condition exclusive to these sports, it is possible to develop tennis or golfer’s elbow even if you have never played either game in your life.

    Below you will find important information about this painful condition, including why it occurs, how to determine if you have the condition, and what treatment options are available.

    Young woman experiencing pain while exercising in a gym.

    Understanding tennis/golfer’s elbow

    Tennis/golfer’s elbow is one of the most common causes of elbow pain. It is often persistent and painful enough to warrant physical therapy and/or a doctor’s visit. This condition occurs when the tendons that connect your forearm to the outside of the elbow bone become swollen and inflamed.

    If this happens, it can lead to microscopic tears in the muscles and tendons. These tears can cause a lot of pain, even though they are very small.

    Usually people don’t experience these symptoms unless they do a lot of repetitive movements. While the general population is not highly likely to experience this pain, as many as half of all players will experience it at some point in their lives.

    What causes tennis/golfer’s elbow?

    If you’re wondering what the causes are, the answer is: a lot of things! As mentioned, tennis/golfer’s elbow usually occurs as a result of repetitive movements of the elbow joint. Besides tennis and golf, some other activities that can lead to elbow pain and discomfort include:

    • Screens
    • Squash
    • Weightlifting
    • Racketball
    • Rake
    • Typing
    • To paint
    • Carpentry
    • To knit
    • Gardening
    • Swimming

    Did some of the items in the list above surprise you? Fortunately, there are things you can do to reduce the chance of developing elbow pain or minimize symptoms if you already have it. Keep reading to learn more.

    Man with elbow pain while playing tennis

    5 Symptoms of tennis/golfer’s elbow

    Are you experiencing elbow pain that makes you wonder if you have tennis/golfer’s elbow or something else? Although a doctor or therapist should be consulted to make the most accurate diagnosis, these are five common symptoms:

    1. Discomfort when you lift something
    2. Weakness in your hand or forearm when making a fist or grabbing something
    3. Recurring pain just below the bend in your elbow (on the outside of your forearm)
    4. Pain that radiates from the elbow to the wrist
    5. Discomfort when turning the forearm (for example, when opening a jar or a door)

    As you can see, the primary symptom is pain in the elbow area. Conditions that mimic tennis elbow include:

    • Radiocapitellar arthritis
    • Osteochondritis dissecans
    • Intra-articular plica
    • Rotational instability

    A visit to your PT can help rule out these conditions if you are unsure whether you have tennis/golfer’s elbow or another condition.

    FH Shin Splits Blog 1

    Prevention techniques

    The best way to prevent developing this condition is to avoid doing repetitive movements too often. If you play a sport or other activity that requires repetitive use of your arm and muscles, make sure you take regular breaks. Stretch the muscles of your arms during your breaks.

    It is also important to warm up the muscles of your arms before doing any physical activity that requires the use of your elbows and/or arms. When the muscles are warm, they can stretch and contract more easily without causing injury.

    Once you’ve finished a sporting event or workout and stretched your arm muscles, consider applying ice to your elbows if you feel heat or inflammation in those areas. If you already have symptoms of tennis elbow despite your best efforts, consider getting physical therapy.

    Physiotherapy treatment options

    Physical therapy can help improve the flexibility and strength of your forearm muscles, making you less likely to develop tennis elbow. Physical therapy can also facilitate healing and reduce pain by stimulating blood flow to the affected tendons and muscles. Blood contains oxygen, which the muscles need to heal and function optimally.

    Six common physical therapy treatment options recommended for tennis elbow:

    1. Muscle stimulation
    2. Ultrasound
    3. Ice massage
    4. Braces and tape to support the affected area
    5. Specialized stretches and exercises
    6. Nonsteroidal anti-inflammatory drugs

    During your recovery from tennis/golfer’s elbow, it is important not to rush things. If you push your body before it is ready and your condition has healed enough, you can set yourself back. Before returning to your previous activity level, make sure that you can grasp objects without pain and that your elbow no longer looks or feels swollen. When you can bend and move your affected elbow without difficulty or discomfort, you can resume your normal activities.

    Get your quality of life back

    If you are ready to get your life back and fully recover from the symptoms of your tennis/golfer’s elbow, we are here to help. Contact Foothills Sports Medicine Physical Therapy today request your appointment.

    Source link